MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on October 24, 2008; DOI: 10.1124/mol.108.050906


0026-895X/09/7501-235-241$20.00
Mol Pharmacol 75:235-241, 2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.108.050906v1
75/1/235    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, L.
Right arrow Articles by Manning, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, L.
Right arrow Articles by Manning, D. R.

The Gq and G12 Families of Heterotrimeric G Proteins Report Functional Selectivity

Li Zhang, Lawrence F. Brass, and David R. Manning

From the Departments of Pharmacology (L.Z., D.R.M.) and Medicine (L.F.B.), University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania

Receptors coupled to the Gq and G12 families of heterotrimeric G proteins have surfaced rarely in the context of functional selectivity and always indirectly. We explore here the differential engagement of Gq and G13 (of the G12 family) by the thromboxane A2 receptor {alpha} (TP{alpha}), via agonist-effected [35S]-guanosine 5'-O-(3-thio)triphosphate binding when the G proteins themselves are used as reporters. We find for TP{alpha} introduced into human embryonic kidney 293 cells and for the receptor expressed normally in human platelets an agonist-selective engagement of Gq versus G13. Pinane thromboxane A2 (PTA2) activates Gq in preference to G13, whereas 8-iso-prostaglandin F2{alpha} activates G13 in preference to Gq. 9,11-Dideoxy-9{alpha},11{alpha}-methanoepoxy-prosta-5Z,13E-dien-1-oic acid (U46619 [GenBank] ), in contrast, exhibits no preference. Reserve of receptor in relation to G protein and of G protein in relation to downstream events is apparent in some instances but does not have a bearing on selectivity. Activation of G proteins by PTA2 is right-shifted from binding of the ligand to receptor, a manifestation of which is a bimodal action: PTA2 is an antagonist at low concentrations and an agonist at higher concentrations. We posit two populations of TP{alpha}, or two intrinsic sites of ligand binding, with selectivity evident not only in terms of the G proteins activated but properties of antagonism versus agonism.


Received July 29, 2008; accepted October 24, 2008

Address correspondence to: David R. Manning, Department of Pharmacology, University of Pennsylvania School of Medicine, 3620 Hamilton Walk, Philadelphia, PA 19104-6084. E-mail: manning{at}mail.med.upenn.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2009 by the American Society for Pharmacology and Experimental Therapeutics